DSM acquires Amyris's flavor, fragrance biobased intermediates business
09:05 AM | March 31, 2021 | Sotirios Frantzanas
Transaction valued at $150 million, completion expected on Wednesday.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.